PRTN3 and rheumatoid arthritis: Nevertheless, the available data could suggest that auto-antibody-positive RA-patients achieving SDFR represent of subgroup of patients with specific characteristics at baseline (Fig. 3); less clinically apparent and MRI-detected joint-inflammation and different auto-antibody-characteristics (less ACPA Fab-glycosylation).